Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05216120
Title Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors HonorHealth Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST